Analysis of Creatine Kinase Activity in 504 Patients with Proximal Spinal Muscular Atrophy Types I–III from the Point of View of Progression and Severity

@article{RudnikSchneborn1998AnalysisOC,
  title={Analysis of Creatine Kinase Activity in 504 Patients with Proximal Spinal Muscular Atrophy Types I–III from the Point of View of Progression and Severity},
  author={Sabine Rudnik-Sch{\"o}neborn and Susanne L{\"u}tzenrath and Janina Borkowska and A. Karwańska and Irena Hausmanowa-Petrusewicz and Klaus Zerres},
  journal={European Neurology},
  year={1998},
  volume={39},
  pages={154 - 162}
}
Mild to moderately elevated creatine kinase (CK) activity is a frequent biochemical finding in proximal spinal muscular atrophy (SMA). In a collaborative study on all types of childhood and juvenile onset SMA, we analysed the CK activity of 504 SMA patients (138 type I, 127 type II, 144 type IIIa, and 95 type IIIb patients). Under the assumption of a lognormal distribution of CK activity as the most appropriate statistical model, CK levels were transformed into logarithms and compared by… Expand
Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis
TLDR
Genetic testing for SBMA is recommended in cases of male patients with motor neuron disease who present with a significantly elevated serum creatine kinase level, even when other characteristic clinical features of SBMA are absent. Expand
Creatine Kinase Revisited
TLDR
Creatine kinase (CK) is the single most important biochemical test in the evaluation of patients with myopathies and may be elevated in neurogenic disorders, particularly in Kennedy's disease and type III spinal muscular atrophy. Expand
Differential Diagnosis of HyperCKemia
TLDR
This review includes an algorithm for the differential diagnosis of CK elevation in patients without muscular symptoms and data from recent studies indicate that the upper limits of normal (ULN) need to be revised upward. Expand
Value of muscle enzyme measurement in evaluating different neuromuscular diseases.
TLDR
This investigation described muscle enzyme profiles in a large cohort of Chinese patients with neuromuscular diseases and found that muscle enzyme values may have some implications for making decision when the diagnosis is hard. Expand
Spinal Muscular Atrophies
TLDR
With respect to most of the nonproximal SMAs and autosomal dominant forms of SMAs, the genetic basis remains to be identified at the time of writing (February 2011). Expand
Observational study of spinal muscular atrophy type I and implications for clinical trials
TLDR
Infants with SMA-I can be effectively enrolled and retained in a 12-month natural history study until a majority reach the combined endpoint of death, and these outcome data can be used for clinical trial design. Expand
A 54-Year-Old Man with Progressive Lower Limb Weakness and CK Elevation
  • Lan Zhou
  • Medicine
  • A Case-Based Guide to Neuromuscular Pathology
  • 2019
TLDR
A patient with FALS caused by an SOD1 gene mutation is described, which had been misdiagnosed with lumbosacral polyradiculopathy and myopathy for 2 years and shows prominent chronic active denervation with pseudomyopathic changes. Expand
Chapter 89 – Spinal Muscular Atrophy
TLDR
Therapeutic development aimed at restoring SMN has been the most successful, and currently gene therapy to replace SMN1 and antisense oligonucleotide therapy to increase SMN production from SMN2 show the most promise. Expand
Creatine kinase monitoring in sport medicine.
TLDR
It is probably safe to counsel athletes with suspected myopathy to continue to undertake physical activity at a lower intensity, so as to prevent muscle damage from high intensity exercise and allow ample recovery to favour adequate recovery. Expand
Spinal Muscular Atrophy: Present State
TLDR
Genetic evidence indicates thatSMN2, a gene 99% identical to SMN1, can attenuate SMA severity: in patients, more SMN2 copies and higher SMN protein levels are correlated with milder SMA. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications.
TLDR
The definition of long-term characteristics of SMA is helpful in providing medical care to families with members who have SMA and also in providing important information for future genotype-phenotype studies and therapeutic trials of patients with SMA. Expand
Creatine phosphokinase activity in spinal muscular atrophy
TLDR
The creatine phosphokinase level in serum was investigated in 17 patients suffering from the spinal muscular atrophy of Kugelberg-Welander, and an increase in the CPK content was found in 12 patients, mostly in cases with pseudomyopathic changes in muscle in biopsy specimens. Expand
A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients
TLDR
Clinical data provide a reliable basis of the natural history of proximal SMA and support a classification system that is based primarily on age at onset and the achievement of motor milestones. Expand
The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. I. Analysis of results from 29 studies.
TLDR
Examination of the method of moments estimates of the parameters suggests that the logarithm of the serum CPK activity in controls may be distributed normally and with stable variance, and the distribution in carriers is not so clear and no such maneuver seems appropriate. Expand
Wohlfart-Kugelberg-Welander syndrome: serum creatine kinase and functional outcome.
TLDR
The medical records of 31 patients with clinical and electrophysiologic features of Wohlfart-Kugelberg-Welander syndrome were reviewed, and proximal muscle weakness, especially of the lower extremities, and muscular atrophy were the predominant clinical features. Expand
The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. II. Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity.
TLDR
It is concluded that for practical purposes, normal daily activity, the stage of the menstrual cycle and the use of the contraceptive pill do not affect CPK activity, and the CPK will probably remain the principal corroborative test for this purpose. Expand
Heterogeneity of serum creatine kinase activity among racial and gender groups of the population.
To develop reference ranges for creatine kinase (CK) appropriate for the patient population served by this hospital, levels of serum CK were measured in 1,537 individuals in our employee population.Expand
Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
TLDR
The occurrence of SMN deletions in unaffected individuals suggests that other genes or mechanisms may be necessary to produce the SMA phenotype, and the largest divergence between age at onset of an affected subject and the present age of unaffected deleted sibs is four decades now. Expand
Infantile and juvenile spinal muscular atrophy.
Abstract Our present clinical and laboratory data, as well as analysis of the pedigrees, seem to indicate that the different forms of spinal muscular atrophy are merely variants of the same diseaseExpand
Spinal Muscular Atrophy: Infantile and Juvenile Type
TLDR
This book reflects the author's extensive personal experience with the spectrum of spinal muscular atrophies of infancy and childhood and can be highly recommended to pediatric neurologists, geneticists, and others who have a special interest in this group of disorders. Expand
...
1
2
3
...